Deltec Asset Management’s Ocular Therapeutix OCUL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $25.9M | Buy |
|
|||||
|
2025
Q1 | $19.9M | Buy |
|
|||||
|
2024
Q4 | $22.3M | Buy |
|
|||||
|
2024
Q3 | $22.6M | Buy |
|
|||||
|
2024
Q2 | $17.7M | Buy |
|
|||||
|
2024
Q1 | $21.5M | Sell |
|
|||||
|
2023
Q4 | $10.9M | Buy |
|
|||||
|
2023
Q3 | $6.47M | Buy |
|
|||||
|
2023
Q2 | $10.2M | Buy |
|
|||||
|
2023
Q1 | $10.1M | Buy |
|
|||||
|
2022
Q4 | $5.21M | Sell |
|
|||||
|
2022
Q3 | $9.64M | Buy |
|
|||||
|
2022
Q2 | $8.32M | Sell |
|
|||||
|
2022
Q1 | $10.3M | Sell |
|
|||||
|
2021
Q4 | $14.6M | Sell |
|
|||||
|
2021
Q3 | $21.5M | Sell |
|
|||||
|
2021
Q2 | $30.7M | Buy |
|
|||||
|
2021
Q1 | $34.4M | Sell |
|
|||||
|
2020
Q4 | $44.9M | Sell |
|
|||||
|
2020
Q3 | $18.8M | Buy |
|
|||||
|
2020
Q2 | $19.4M | Buy |
|
|||||
|
2020
Q1 | $10.3M | Sell |
|
|||||
|
2019
Q4 | $8.39M | Buy |
|
|||||
|
2019
Q3 | $6.11M | Buy |
|
|||||
|
2019
Q2 | $6.23M | Buy |
|
|||||
|
2019
Q1 | $3.27M | Buy |
|
|||||
|
2018
Q4 | $2.88M | Buy |
|
|||||
|
2018
Q3 | $4.27M | Buy |
|
|||||
|
2018
Q2 | $3.6M | Sell |
|
|||||
|
2018
Q1 | $3.82M | Buy |
|
|||||
|
2017
Q4 | $953K | Sell |
|
|||||
|
2017
Q3 | $1.91M | Sell |
|
|||||
|
2017
Q2 | $3.26M | Sell |
|
|||||
|
2017
Q1 | $3.71M | Buy |
|
|||||
|
2016
Q4 | $963K | Buy |
|